Basis of Presentation and Summary of Significant Accounting Policies (Revenue and Gross Trade Receivables Percentage by Major Customers) (Details) - Pharmaceutical and Specialty Solutions	12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2023
CVS Health Corporation
Revenue, Major Customer [Line Items]
Percent of Gross Trade Receivables	26.00%	22.00%
CVS Health Corporation | Revenue Benchmark | Customer Concentration Risk
Revenue, Major Customer [Line Items]
Concentration Risk, Percentage	30.00%	24.00%	25.00%
OptumRx [Member]
Revenue, Major Customer [Line Items]
Percent of Gross Trade Receivables	0.00%	6.00%
OptumRx [Member] | Revenue Benchmark | Customer Concentration Risk
Revenue, Major Customer [Line Items]
Concentration Risk, Percentage	0.00%	17.00%	16.00%